-
Plasma-Centric Drugmaker Grifols To Buy Geriatric Pharma Startup Alkahest
Tuesday, September 8, 2020 - 2:17am | 352Read More...Blood plasma and diagnostics company Grifols SA (NASDAQ: GRFS) is set to completely acquire Alkahest Inc, a biopharmaceutical startup focussed on neurodegenerative and age-related diseases, for $146 million on a debt-free basis. What Happened: Grifols will buy the remaining equity in Alkahest...
-
Plasma Treatment For COVID-19 Unlikely To Be 'Home Run,' Says Ex-FDA Commissioner
Monday, August 24, 2020 - 2:27pm | 476Read More...The FDA granted emergency authorization of convalescent plasma to treat hospitalized COVID-19 patients on Sunday, and this could be helpful in treating sick people, former FDA Commissioner Dr. Scott Gottlieb said on CNBC's "Squawk Box." An Important Distinction: It may be...
-
PreMarket Prep Stock Of The Day: ADMA Biologics
Monday, August 24, 2020 - 12:37pm | 755Read More...Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session. On any given...
-
These Plasma Stocks Are Surging After FDA's Convalescent EUA
Monday, August 24, 2020 - 9:34am | 818Read More...Health care stocks levered to blood collection and sampling, and plasma therapy biopharma companies are getting a big boost Monday after the FDA issued emergency use authorization for the use of investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients. The EUA,...
-
Cerus Higher Following Agreement With Blood Systems, Inc.
Tuesday, January 5, 2016 - 1:15pm | 130Read More...Shares of Cerus Corporation (NASDAQ: CERS), a biomedical products company, jumped higher by nearly 2 percent on Tuesday after the company announced a master agreement with Blood Systems, Inc. (BSI) for the use of INTERCEPT Blood System for platelets and plasma. BSI and its affiliates distribute 240...
